Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats - Anegkamol, Weerapat; Bowonsomsarit, Wirin; Taweevisit, Mana; Tumwasorn, Somying; Thongsricome, Thana; Kaewwongse, Maroot; Pitchyangkura, Rath; Tosukhowong, Piyaratana; Chuaypen, Natthaya; Dissayabutra, Thasinas (Scientific reports, 2025)
Keywords: 631/326/2565/2134; 692/699/1585/104; 692/699/1585/1732; Animal models; Animals; Bone diseases; Calcification (ectopic); Calcium phosphates; Cardiovascular diseases; Chitosan; Chronic kidney disease; Cisplatin; Disease Models, Animal; Fructooligosaccharides; Humanities and Social Sciences; Hyperparathyroidism; Hyperparathyroidism, Secondary - etiology; Hyperparathyroidism, Secondary - therapy; Hyperphosphatemia; Hyperphosphatemia - blood; Hyperphosphatemia - etiology; Hyperphosphatemia - therapy; Kidney diseases; Male; multidisciplinary; Oligosaccharides - administration & dosage; Paracellular transport; Parathyroid hormone; Parathyroid Hormone - blood; Phosphate; Phosphates - blood; Pre-eclampsia; Probiotics; Rats; Renal Insufficiency, Chronic - chemically induced; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - therapy; Science; Science (multidisciplinary); Synbiotics; Synbiotics - administration & dosage; Tight junction; Tight junction; Chronic kidney disease; Phosphate; Paracellular transport; Synbiotics; Hyperparathyroidism